R. F. Ritchie, G. E. Palomaki, L. M. Neveux, O. Navolotskaia, T. B. Ledue et al., Reference distributions for immunoglobulins A, G, and M: A practical, simple, and clinically relevant approach in a large cohort, J Clin Lab Anal. 1 janv, vol.12, issue.6, pp.363-70, 1998.

E. Oksenhendler, L. Gérard, C. Fieschi, M. Malphettes, G. Mouillot et al., Infections in 252 Patients with Common Variable Immunodeficiency, Clin Infect Dis. 15 mai, vol.46, issue.10, pp.1547-54, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00453187

R. Ameratunga, M. Brewerton, C. Slade, A. Jordan, D. Gillis et al., Comparison of diagnostic criteria for common variable immunodeficiency disorder, Front Immunol, vol.5, p.415, 2014.

C. Rozman, E. Montserrat, and N. Viñolas, Serum immunoglobulins in B-chronic lymphocytic leukemia. Natural history and prognostic significance, Cancer. 15 janv, vol.61, issue.2, pp.279-83, 1988.

R. A. Kyle, M. A. Gertz, T. E. Witzig, J. A. Lust, M. Q. Lacy et al., Review of 1027 patients with newly diagnosed multiple myeloma, Mayo Clin Proc. janv, vol.78, issue.1, pp.21-33, 2003.

F. Dhalla and S. A. Misbah, Secondary antibody deficiencies, Curr Opin Allergy Clin Immunol. déc, vol.15, issue.6, pp.505-518, 2015.

J. A. Freeman, K. R. Crassini, O. G. Best, C. J. Forsyth, N. J. Mackinlay et al., Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia, Leuk Lymphoma. janv, vol.54, issue.1, pp.99-104, 2013.

D. T. Alexandrescu and P. H. Wiernik, Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia, Med Oncol. 5 janv, vol.25, issue.3, pp.309-323, 2008.

P. L. Amlot, L. Green, A. Serum-immunoglobulins-g, and M. , Br J Cancer. sept, vol.40, issue.3, pp.371-380, 1979.

A. Lichtenstein and C. R. Taylor, Serum immunoglobulin levels in patients with non-Hodgkin's lymphoma, Am J Clin Pathol. juill, vol.74, issue.1, pp.12-19, 1980.

A. E. Grulich, C. M. Vajdic, S. Riminton, A. M. Hughes, A. Kricker et al., Re: Atopy and Risk of Non-Hodgkin lymphoma, JNCI J Natl Cancer Inst, vol.99, issue.18, pp.1417-1417, 2007.

R. J. Biggar, M. Christiansen, K. Rostgaard, K. E. Smedby, H. Adami et al., Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma, Int J Cancer. 1 juin, vol.124, issue.11, pp.2616-2636, 2009.

A. Planinc-peraica, S. O. Koloni?, D. Radi?-kristo, M. Dominis, and B. Jaksi?, Serum immunoglobulins in non-Hodgkin's lymphoma patients, Coll Antropol. juin, vol.34, issue.2, pp.407-418, 2010.

C. Casulo, J. Maragulia, and A. D. Zelenetz, Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections, Clin Lymphoma Myeloma Leuk. avr, vol.13, issue.2, pp.106-117, 2013.

B. I. Hoffbrand, Hodgkin's Disease and Hypogammaglobulinaemia: A Rare Association, Br Med J. 2 mai, vol.1, issue.5391, pp.1156-1164, 1964.

H. Fudenberg, R. A. Good, H. C. Goodman, W. Hitzig, H. G. Kunkel et al., Primary Immunodeficiencies. Pediatrics. 1 mai, vol.47, issue.5, pp.927-973, 1971.

G. J. Driessen, V. Dalm, H. A. Hagen-pm-van,-grashoff, N. G. Hartwig, A. Rossum et al., Common variable immunodeficiency and idiopathic primary hypogammaglobulinemia: two different conditions within the same disease spectrum, Haematologica, vol.98, issue.10, pp.1617-1640, 2013.

M. Malphettes, L. Gérard, M. Carmagnat, G. Mouillot, N. Vince et al., Late-Onset Combined Immune Deficiency: A Subset of Common Variable Immunodeficiency with Severe T Cell Defect, Clin Infect Dis, vol.49, issue.9, pp.1329-1367, 2009.

R. Bertinchamp, L. Gérard, D. Boutboul, M. Malphettes, C. Fieschi et al., Exclusion of Patients with a Severe T-Cell Defect Improves the Definition of Common Variable Immunodeficiency, J Allergy Clin Immunol Pract. 10 août, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01828815

P. Kirkpatrick and S. Riminton, Primary Immunodeficiency Diseases in Australia and New Zealand, J Clin Immunol. 1 sept, vol.27, issue.5, pp.517-541, 2007.

H. Chapel and C. Cunningham-rundles, Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions, Br J Haematol. 1 juin, vol.145, issue.6, pp.709-736, 2009.

J. Edgar, M. Buckland, D. Guzman, N. P. Conlon, V. Knerr et al., The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity, Clin Exp Immunol. janv, vol.175, issue.1, pp.68-78, 2008.

L. Westh, T. H. Mogensen, L. S. Dalgaard, B. Jensen, J. M. Katzenstein et al., Identification and Characterization of a Nationwide Danish Adult Common Variable Immunodeficiency Cohort, Scand J Immunol. 1 juin, vol.85, issue.6, pp.450-61, 2017.

E. S. Resnick, E. L. Moshier, J. H. Godbold, and C. Cunningham-rundles, Morbidity and mortality in common variable immune deficiency over 4 decades, Blood. 16 févr, vol.119, issue.7, pp.1650-1657, 2012.

H. Chapel, M. Lucas, S. Patel, M. Lee, C. Cunningham-rundles et al., Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts, J Allergy Clin Immunol, vol.130, issue.5, pp.1197-1198, 2012.

B. Gathmann, N. Mahlaoui, C. Gérard, L. Oksenhendler, E. Warnatz et al., Clinical picture and treatment of 2212 patients with common variable immunodeficiency, J Allergy Clin Immunol. juill, vol.134, issue.1, pp.116-142, 2014.

M. M. Gompels, E. Hodges, R. J. Lock, B. Angus, H. White et al., Lymphoproliferative disease in antibody deficiency: a multi-centre study, Clin Exp Immunol, vol.134, issue.2, pp.314-334, 2003.

G. Malamut, M. Ziol, F. Suarez, M. Beaugrand, J. F. Viallard et al., Nodular regenerative hyperplasia: The main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities, J Hepatol. 1 janv, vol.48, issue.1, pp.74-82, 2008.

I. J. Fuss, J. Friend, Z. Yang, P. He, L. Hooda et al., Nodular Regenerative Hyperplasia in Common Variable Immunodeficiency, J Clin Immunol. mai, vol.33, issue.4, p.748, 2013.

H. Chapel, M. Lucas, M. Lee, J. Bjorkander, D. Webster et al., Common variable immunodeficiency disorders: division into distinct clinical phenotypes, Blood. 15 juill, vol.112, issue.2, pp.277-86, 2008.

C. M. Vajdic, L. Mao, M. T. Van-leeuwen, P. Kirkpatrick, A. E. Grulich et al., Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency?, Blood. 26 août, vol.116, issue.8, pp.1228-1262, 2010.

K. Warnatz, A. Denz, R. Dräger, M. Braun, C. Groth et al., Severe deficiency of switched memory B cells (CD27 + IgM ? IgD ? ) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease, Blood. 1 mars, vol.99, issue.5, pp.1544-51, 2002.

C. Wehr, T. Kivioja, C. Schmitt, B. Ferry, T. Witte et al., The EUROclass trial: defining subgroups in common variable immunodeficiency, Blood. 1 janv, vol.111, issue.1, pp.77-85, 2008.

R. Ameratunga, S. Woon, D. Gillis, W. Koopmans, and R. Steele, New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin, Clin Exp Immunol, vol.174, issue.2, pp.203-214, 2013.

M. E. Conley, L. D. Notarangelo, and A. Etzioni, Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies), Clin Immunol Orlando Fla. déc, vol.93, issue.3, pp.190-197, 1999.

Y. Levy, N. Gupta, F. L. Deist, C. Garcia, A. Fischer et al., Defect in IgV gene somatic hypermutation in Common Variable Immuno-Deficiency syndrome, Proc Natl Acad Sci, vol.95, issue.22, pp.13135-13175, 1998.

D. Bonhomme, L. Hammarström, D. Webster, H. Chapel, O. Hermine et al., Impaired Antibody Affinity Maturation Process Characterizes a Subset of Patients with Common Variable Immunodeficiency, J Immunol, vol.165, issue.8, pp.4725-4755, 2000.

P. Andersen, H. Permin, V. Andersen, L. Schejbel, P. Garred et al., Deficiency of somatic hypermutation of the antibody light chain is associated with increased frequency of severe respiratory tract infection in common variable immunodeficiency, Blood. 15 janv, vol.105, issue.2, pp.511-518, 2005.

A. Giovannetti, M. Pierdominici, F. Mazzetta, M. Marziali, C. Renzi et al., Unravelling the Complexity of T Cell Abnormalities in Common Variable Immunodeficiency, J Immunol. 15 mars, vol.178, issue.6, pp.3932-3975, 2007.

. Bateman-e-a.-l, L. Ayers, R. Sadler, M. Lucas, C. Roberts et al., T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections, Clin Exp Immunol, vol.170, issue.2, pp.202-213, 2012.

D. Moratto, A. V. Gulino, S. Fontana, L. Mori, S. Pirovano et al., Combined decrease of defined B and T cell subsets in a group of common variable immunodeficiency patients, Clin Immunol Orlando Fla, vol.121, issue.2, pp.203-217, 2006.

J. Viallard, C. Ruiz, M. Guillet, J. Pellegrin, and J. Moreau, Perturbations of the CD8+ T-cell repertoire in CVID patients with complications, Results Immunol. 1 janv, vol.3, pp.122-130, 2013.

J. Iglesias, N. Matamoros, S. Raga, J. M. Ferrer, and J. Mila, CD95 expression and function on lymphocyte subpopulations in common variable immunodeficiency (CVID); related to increased apoptosis, Clin Exp Immunol. juill, vol.117, issue.1, pp.138-184, 1999.

G. Mouillot, M. Carmagnat, L. Gérard, J. Garnier, C. Fieschi et al., B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease, J Clin Immunol. sept, vol.30, issue.5, pp.746-55, 2010.

B. Fevang, A. Yndestad, W. J. Sandberg, A. M. Holm, F. Müller et al., Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo, Clin Exp Immunol. 1 mars, vol.147, issue.3, pp.521-526, 2007.

N. Arandi, A. Mirshafiey, M. Jeddi-tehrani, H. Abolhassani, B. Sadeghi et al., Evaluation of CD4+CD25+FOXP3+ regulatory T cells function in patients with common variable immunodeficiency, Cell Immunol. févr, vol.281, issue.2, pp.129-162, 2013.

R. R. Barbosa, S. P. Silva, S. L. Silva, A. C. Melo, P. E. Barbosa et al., Primary B-Cell Deficiencies Reveal a Link between Human IL-17-Producing CD4 T-Cell Homeostasis and B-Cell Differentiation, PLOS ONE. août, vol.6, issue.8, p.22848, 2011.

S. Unger, M. Seidl, P. Van-schouwenburg, M. Rakhmanov, A. Bulashevska et al., The TH1 phenotype of follicular helper T cells indicates an IFN-?-associated immune dysregulation in patients with CD21low common variable immunodeficiency, J Allergy Clin Immunol. 26 mai, 2017.

V. Cunill, A. Clemente, N. Lanio, C. Barceló, V. Andreu et al., Follicular T Cells from smB(-) Common Variable Immunodeficiency Patients Are Skewed Toward a Th1 Phenotype, Front Immunol, vol.8, p.174, 2017.

L. Hammarström, I. Vorechovsky, and D. Webster, Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID), Clin Exp Immunol. mai, vol.120, issue.2, pp.225-256, 2000.

C. Rivoisy, L. Gérard, D. Boutboul, M. Malphettes, C. Fieschi et al., Parental Consanguinity is Associated with a Severe Phenotype in Common Variable Immunodeficiency, J Clin Immunol. 1 févr, vol.32, issue.1, pp.98-105, 2012.

A. Aghamohammadi, P. Mohammadinejad, H. Abolhassani, B. Mirminachi, M. Movahedi et al., Primary Immunodeficiency Disorders in Iran: Update and New Insights from the Third Report of the National Registry, J Clin Immunol. 1 mai, vol.34, issue.4, pp.478-90, 2014.

C. Picard, W. Al-herz, A. Bousfiha, J. Casanova, T. Chatila et al., Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency, J Clin Immunol, vol.35, issue.8, pp.696-726, 2015.

D. Bogaert, M. Dullaers, B. N. Lambrecht, K. Y. Vermaelen, E. D. Baere et al., Genes associated with common variable immunodeficiency: one diagnosis to rule them all, J Med Genet. 1 sept, vol.53, issue.9, pp.575-90, 2016.

L. Mellemkjaer, L. Hammarström, V. Andersen, J. Yuen, C. Heilmann et al., Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study, Clin Exp Immunol. 1 déc, vol.130, issue.3, pp.495-500, 2002.

C. Cunningham-rundles, P. Lieberman, G. Hellman, and R. S. Chaganti, Non-Hodgkin lymphoma in common variable immunodeficiency, Am J Hematol. juin, vol.37, issue.2, pp.69-74, 1991.

C. Cunningham-rundles and C. Bodian, Common Variable Immunodeficiency: Clinical and Immunological Features of 248 Patients, Clin Immunol. 1 juill, vol.92, issue.1, pp.34-48, 1999.

I. Quinti, C. Agostini, S. Tabolli, G. Brunetti, F. Cinetto et al., Malignancies are the major cause of death in patients with adult onset common variable immunodeficiency. Blood, vol.120, pp.1953-1957, 2012.

L. J. Kinlen, A. D. Webster, A. G. Bird, R. Haile, J. Peto et al., Prospective study of cancer in patients with hypogammaglobulinaemia, Lancet Lond Engl. 2 févr, vol.1, issue.8423, pp.263-269, 1985.

C. Cunningham-rundles, F. P. Siegal, S. Cunningham-rundles, and P. Lieberman, Incidence of cancer in 98 patients with common varied immunodeficiency, J Clin Immunol. juill, vol.7, issue.4, pp.294-303, 1987.

I. Quinti, A. Soresina, G. Spadaro, S. Martino, S. Donnanno et al., Long-Term Follow-Up and Outcome of a Large Cohort of Patients with Common Variable Immunodeficiency, J Clin Immunol. 1 mai, vol.27, issue.3, pp.308-324, 2007.

H. Abolhassani, A. Aghamohammadi, A. Imanzadeh, P. Mohammadinejad, B. Sadeghi et al., Malignancy phenotype in common variable immunodeficiency, J Investig Allergol Clin Immunol, vol.22, issue.2, pp.133-137, 2012.

B. Sini, C. K. Debora, L. , J. P. , A. Karolina et al., Frequency of lymphomas in a cohort of Common Variable Immunodeficiency (CVID) patients. Front Immunol, 2013.

C. Ariatti, D. Vivenza, D. Capello, A. Migliazza, G. Parvis et al., Common-variable immunodeficiency-related lymphomas associate with mutations and rearrangements of BCL-6: Pathogenetic and histogenetic implications, Hum Pathol. 1 juill, vol.31, issue.7, pp.871-874, 2000.

C. Cunningham-rundles, D. L. Cooper, T. P. Duffy, and J. Strauchen, Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency, Am J Hematol. mars, vol.69, issue.3, pp.171-179, 2002.

D. Gratzinger, E. S. Jaffe, A. Chadburn, J. Chan, D. De-jong et al., Primary/Congenital Immunodeficiency2015 SH/EAHP Workshop Report-Part 5, Am J Clin Pathol. 1 févr, vol.147, issue.2, pp.204-220, 2017.

I. Desar, M. Keuter, J. Raemaekers, J. Jansen, J. Van-krieken et al., Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency, Neth J Med. mai, vol.64, issue.5, pp.136-176, 2006.

A. Aghamohammadi, N. Parvaneh, F. Tirgari, F. Mahjoob, M. Movahedi et al., Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency, Leuk Lymphoma. 1 janv, vol.47, issue.2, pp.343-349, 2006.

D. De-jong, M. Roemer, J. Chan, J. Goodlad, D. Gratzinger et al., B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency2015 SH/EAHP Workshop Report-Part 2, Am J Clin Pathol. 1 févr, vol.147, issue.2, pp.153-70, 2017.

C. Cunningham-rundles, F. P. Siegal, S. Cunningham-rundles, and P. Lieberman, Incidence of cancer in 98 patients with common varied immunodeficiency, J Clin Immunol. juill, vol.7, issue.4, pp.294-303, 1987.

M. N. Polizzotto, J. S. Mccomish, M. A. Dawson, S. S. Opat, and C. Mf, Burkitt lymphoma in the setting of common variable immunodeficiency, Ann Hematol. 1 août, vol.88, issue.8, pp.819-839, 2009.

C. Ganzel, J. M. Rowe, and R. Ruchlemer, Primary effusion lymphoma in a HIV-negative patient associated with hypogammaglobulinemia, Am J Hematol. 1 sept, vol.86, issue.9, pp.777-81, 2011.

S. Gottesman, D. Haas, M. Ladanyi, and E. L. Amorosi, Peripheral T Cell Lymphoma in a Patient with Common Variable Immunodeficiency Disease: Case Report and Literature Review, Leuk Lymphoma. 1 janv, vol.32, issue.5-6, pp.589-95, 1999.

D. Suan, J. Koutts, M. Tschuchnigg, M. Shingde, S. Jolles et al., Cytotoxic T-cell lymphoma complicating common variable immunodeficiency, Pathology (Phila). 1 janv, vol.43, issue.1, pp.75-83, 2011.

A. A. Jesus, C. Jacob, C. A. Silva, M. Dorna, A. C. Pastorino et al., Common Variable Immunodeficiency Associated with Hepatosplenic T-Cell Lymphoma Mimicking Juvenile Systemic Lupus Erythematosus, Common Variable Immunodeficiency Associated with Hepatosplenic T-Cell Lymphoma Mimicking Juvenile Systemic Lupus Erythematosus, J Immunol Res J Immunol Res. 27 juin, 2011.

B. Gammon, A. Robson, J. Deonizio, L. Arkin, and J. Guitart, CD8+ granulomatous cutaneous T-cell lymphoma: A potential association with immunodeficiency, J Am Acad Dermatol. 1 sept, vol.71, issue.3, pp.555-60, 2014.

T. Marafioti, M. Hummel, I. Anagnostopoulos, H. Foss, B. Falini et al., Origin of Nodular Lymphocyte-Predominant Hodgkin's Disease from a Clonal Expansion of Highly Mutated Germinal-Center B Cells, N Engl J Med. 14 août, vol.337, issue.7, pp.453-461, 1997.

E. Tchernonog, P. Faurie, P. Coppo, H. Monjanel, A. Bonnet et al., Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group, Ann Oncol. 1 avr, vol.28, issue.4, pp.843-851, 2017.

W. H. Wheat, C. D. Cool, Y. Morimoto, P. R. Rai, C. H. Kirkpatrick et al., Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency, J Exp Med. 15 août, vol.202, issue.4, pp.479-84, 2005.

I. Chua, I. Quinti, and B. Grimbacher, Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics, Curr Opin Hematol. juill, vol.15, issue.4, pp.368-74, 2008.

H. Tran, J. Nourse, S. Hall, M. Green, L. Griffiths et al., Immunodeficiency-associated lymphomas, Blood Rev. sept, vol.22, issue.5, pp.261-81, 2008.

E. Elkaim, B. Neven, J. Bruneau, K. Mitsui-sekinaka, A. Stanislas et al., Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase ? syndrome 2: A cohort study, J Allergy Clin Immunol. juillet, vol.138, issue.1, pp.210-218, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01482361

S. H. Swerdlow, International Agency for Research on Cancer, éditeurs. WHO classification of tumours of haematopoietic and lymphoid tissues. 4. ed. Lyon: Internat. Agency for Research on Cancer, World Health Organization, vol.439, 2008.

C. Laurent, M. Baron, A. N. Haioun, C. Dandoit, M. Maynadié et al., Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network, J Clin Oncol. 1 mai, vol.35, issue.18, pp.2008-2025, 2017.

S. Park, J. Lee, Y. H. Ko, A. Han, H. J. Jun et al., The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma, Blood. 1 août, vol.110, issue.3, pp.972-980, 2007.

M. Hummel, I. Anagnostopoulos, F. Dallenbach, P. Korbjuhn, C. Dimmler et al., EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products, Br J Haematol. 1 déc, vol.82, issue.4, pp.689-94, 1992.

B. Chetaille, F. Bertucci, P. Finetti, B. Esterni, A. Stamatoullas et al., Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome, Blood. 19 mars, vol.113, issue.12, pp.2765-3775, 2009.

C. Fermé, J. Thomas, P. Brice, O. Casasnovas, A. Vranovsky et al., ABVD or BEACOPPbaseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial, Eur J Cancer. 1 août, vol.81, pp.45-55, 2017.

G. Hapgood, Y. Zheng, L. H. Sehn, D. Villa, R. Klasa et al., Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia, J Clin Oncol Off J Am Soc Clin Oncol. 20 juill, vol.34, issue.21, pp.2493-500, 2016.

P. J. Bröckelmann, H. Goergen, C. Kohnhorst, B. Von-tresckow, A. Moccia et al., Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials, J Clin Oncol. mai, vol.35, issue.13, pp.1444-50, 2017.

A. G. Starr, P. F. Caimi, P. Fu, M. R. Massoud, H. Meyerson et al., Dual institution experience of extranodal marginal zone lymphoma reveals excellent long-term outcomes, Br J Haematol. 1 mai, vol.173, issue.3, pp.404-416, 2016.

M. Raderer, B. Kiesewetter, and A. Ferreri, Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma), CA Cancer J Clin. 1 mars, vol.66, issue.2, pp.152-71, 2016.

K. Boslooper, M. Hoogendoorn, E. N. Van-roon, R. E. Kibbelaar, H. Storm et al., No outcome disparities in patients with diffuse large B-cell lymphoma and a low socioeconomic status, Cancer Epidemiol. 1 juin, vol.48, pp.110-116, 2017.

S. L. Guyader-peyrou, O. S. Dejardin, O. Maynadié, M. Troussard, X. Monnereau et al., Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role?, Haematologica. 1 mars, vol.102, issue.3, pp.584-92, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01559872

T. I. De-la, M. J. Leandro, L. Valor, E. Becerra, J. Edwards et al., Total serum immunoglobulin levels in patients with RA after multiple B-cell depletion cycles based on rituximab: relationship with Bcell kinetics, Rheumatol Oxf Engl. mai, vol.51, issue.5, pp.833-873, 2012.

E. Christou, G. Giardino, A. Worth, and F. Ladomenou, Risk factors predisposing to the development of hypogammaglobulinemia and infections post-Rituximab, Int Rev Immunol. 11 août, vol.0, issue.0, pp.1-8, 2017.

M. Nishio, T. Endo, K. Fujimoto, S. Yamamoto, M. Obara et al., FCGR3A-158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin's lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation, Eur J Haematol. févr, vol.82, issue.2, pp.143-150, 2009.

T. H. Mogensen, J. M. Bernth-jensen, C. C. Petersen, M. S. Petersen, C. Nyvold et al., Common variable immunodeficiency unmasked by treatment of immune thrombocytopenic purpura with Rituximab, BMC Blood Disord. 11 avr, vol.13, p.4, 2013.

R. Levy, M. Mahévas, L. Galicier, D. Boutboul, J. Moroch et al., Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia, Autoimmun Rev, vol.13, issue.10, pp.1055-63, 2014.

P. Maffucci, C. A. Filion, B. Boisson, Y. Itan, L. Shang et al., Genetic Diagnosis Using Whole Exome Sequencing in Common Variable Immunodeficiency, Prim Immunodefic, vol.220, 2016.

J. Van-der-werff-ten-bosch and M. Van-den-akker, Genetic predisposition and hematopoietic malignancies in children: Primary immunodeficiency, Eur J Med Genet. déc, vol.59, issue.12, pp.647-53, 2016.

S. P. Silva, . Da, E. Resnick, M. Lucas, J. Lortan et al., Lymphoid Proliferations of Indeterminate Malignant Potential arising in Adults with Common Variable Immunodeficiency Disorders: Unusual Case Studies and Immunohistological Review in the Light of Possible Causative Events, J Clin Immunol. 9 juill, vol.31, issue.5, p.784, 2011.

F. Suarez, O. Lortholary, O. Hermine, and M. Lecuit, Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation, Blood. 15 avr, vol.107, issue.8, pp.3034-3078, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00022498

K. E. Smedby and M. Ponzoni, The etiology of B-cell lymphoid malignancies with a focus on chronic inflammation and infections, J Intern Med

V. V. Joshi, G. A. Gagnon, E. G. Chadwick, C. W. Berard, K. L. Mcclain et al., The spectrum of mucosaassociated lymphoid tissue lesions in pediatric patients infected with HIV: A clinicopathologic study of six cases, Am J Clin Pathol. mai, vol.107, issue.5, pp.592-600, 1997.

E. Boulanger, L. Gérard, J. Gabarre, J. Molina, C. Rapp et al., Prognostic Factors and Outcome of Human Herpesvirus 8-Associated Primary Effusion Lymphoma in Patients With AIDS, J Clin Oncol. 7 janv, vol.23, pp.4372-80, 2005.

T. M. Shehab, E. D. Hsi, J. J. Poterucha, N. T. Gunaratnam, and R. J. Fontana, Helicobacter pylori-associated gastric MALT lymphoma in liver transplant recipients, Transplantation. 27 avr, vol.71, issue.8, pp.1172-1177, 2001.

E. D. Hsi, T. P. Singleton, L. Swinnen, C. H. Dunphy, and S. Alkan, Mucosa-associated lymphoid tissue-type lymphomas occurring in post-transplantation patients, Am J Surg Pathol. janv, vol.24, issue.1, pp.100-106, 2000.

M. Fliegauf, L. Bryant, V. Frede, N. Slade, C. Woon et al., Haploinsufficiency of the NF-?B1 Subunit p50 in Common Variable Immunodeficiency, Am J Hum Genet. 3 sept, vol.97, issue.3, pp.389-403, 2015.

T. I. Coulter, A. Chandra, C. M. Bacon, J. Babar, J. Curtis et al., Clinical spectrum and features of activated phosphoinositide 3-kinase ? syndrome: A large patient cohort study, J Allergy Clin Immunol. 1 févr, vol.139, issue.2, pp.597-606, 2017.

C. L. Lucas, A. Chandra, S. Nejentsev, A. M. Condliffe, and K. Okkenhaug, PI3K? and primary immunodeficiencies, Nat Rev Immunol, vol.16, issue.11, pp.702-716, 2016.

S. Kracker, J. Curtis, M. Ibrahim, A. Sediva, J. Salisbury et al., Occurrence of B-cell lymphomas in patients with Activated Phosphoinositide 3-Kinase ? syndrome, J Allergy Clin Immunol. juill, vol.134, issue.1, pp.233-239, 2014.

S. Sander, D. P. Calado, L. Srinivasan, K. Köchert, B. Zhang et al., Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis, Cancer Cell. 14 août, vol.22, issue.2, pp.167-79, 2012.

E. Bohers, S. Mareschal, P. Bertrand, P. J. Viailly, S. Dubois et al., Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine era, Leuk Lymphoma. mai, vol.56, issue.5, pp.1213-1235, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02332349

B. Kloo, D. Nagel, M. Pfeifer, M. Grau, M. Düwel et al., Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells, Proc Natl Acad Sci, vol.108, issue.1, pp.272-279, 2011.

J. Zhang, V. Grubor, C. L. Love, A. Banerjee, K. L. Richards et al., Genetic heterogeneity of diffuse large B-cell lymphoma, Proc Natl Acad Sci U S A. 22 janv, vol.110, issue.4, pp.1398-403, 2013.

M. Elgizouli, D. M. Lowe, C. Speckmann, D. Schubert, J. Hülsdünker et al., Activating PI3K? mutations in a cohort of 669 patients with primary immunodeficiency, Clin Exp Immunol. 1 févr, vol.183, issue.2, pp.221-230, 2016.